Okamoto Industries (5122) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
7 Aug, 2026Executive summary
Net sales rose 7.4% year-over-year to ¥28,923 million for the quarter ended June 30, 2026, driven by proactive order-taking, price revisions, and favorable foreign exchange effects.
Operating profit surged 90.3% year-over-year to ¥1,549 million, and ordinary profit doubled to ¥2,534 million.
Profit attributable to owners of parent increased 270.9% year-over-year to ¥1,775 million, reflecting higher sales and stabilized raw material costs.
Financial highlights
Gross profit increased to ¥5,744 million from ¥4,640 million year-over-year.
Net income per share rose to ¥104.09 from ¥27.68 year-over-year.
Comprehensive income reached ¥1,505 million, up from ¥271 million in the prior year.
Total assets stood at ¥162,042 million as of June 30, 2026, down slightly from ¥164,167 million at the previous fiscal year-end.
Equity ratio remained stable at 67.4%.
Outlook and guidance
Full-year net sales forecast revised to ¥115,000 million, up 6.4% year-over-year.
Operating income projected at ¥6,700 million, ordinary income at ¥8,700 million, and profit attributable to owners of parent at ¥5,700 million.
Dividend forecast revised upward to ¥130 per share for FY2027.
Latest events from Okamoto Industries
- Net sales grew 6.9% year-over-year, with full acquisition of RIKEN CORUNDUM completed.5122
Q2 2025 - Sales and operating profit rose, but net profit fell on higher impairment losses.5122
Q1 2025 - Sales rose but profits fell due to higher costs and impairments, with lower segment margins.5122
Q3 2025 - Net sales rose 2.8% year-over-year, but profit and operating income declined amid flat FY2026 outlook.5122
Q4 2025 - Net sales rose, but profits declined sharply year-over-year; guidance and dividends unchanged.5122
Q1 2026 - Profits fell sharply on weaker demand and higher costs, but dividends and buybacks continue.5122
Q2 2026 - Profits fell on currency and cost pressures, but full-year guidance remains optimistic.5122
Q3 2026 - Sales and profits fell sharply, with only modest recovery forecast amid ongoing risks.5122
Q4 2026